Using Ruby and R to improve your data skills.
Sau Sheong Chang describes the intriguing projects in his upcoming book, "Exploring Everyday Things with R and Ruby" and how other people can develop their own experiments.
Jan Erik Solem describes elements and useful tools for computer vision
In this interview, Jan Erik Solem, author of the upcoming book "Programming Computer Vision with Python," describes the uses for some common operations, and choices programmers have.
Advice from author of "Version Control with Git."
After finishing the second edition of "Version Control with Git," author Jon Loeliger talked to O'Reilly editor Andy Oram about how to use Git effectively as changes to code pile up.
In health information technology, we have a rare chance to ensure that the most affected members of the public actually have their own direct representative. A letter in support of Regina Holliday.
Great piles of cash are descending on entrepreneurs who develop health care apps, but that doesn't make it any easier to create a useful one that your audience will adopt. About the Spring Fling conference, enterpreneurship, and open data.
With a modern search engine and smart planning, web sites can provide visitors with a better search experience than Google. Why turn-out for the new "big data" track was lower than I expected, and other news from this week's conference about using Lucene big and small.
The letter conveys a rather sorrowful message about the state of health IT in the United States. One request–to put brakes on the requirement for hospitals to let patients see their own information electronically–has received particularly strong coverage and vigorous responses.
Can open data dominate biological science as open source has in software?
To move from a hothouse environment of experimentation to the mainstream of one of the world's most lucrative and tradition-bound industries, Sage Bionetworks must aim for its nucleus: rewards and incentives. Comparisons to open source software and a summary of tasks for Sage Congress.
The Vioxx problem is just one instance of the wider malaise afflicting the drug industry. Managers from major pharma companies expressed confidence that they could expand public or "pre-competitive" research in the direction Sage Congress proposed. The sector left to engage is the one that's central to all this work–the public.
Report from a movement that believes in open source and open data in science
Through two days of demos, keynotes, panels, and breakout sessions, Sage Congress brought its vision to a high-level cohort of 230 attendees from universities, pharmaceutical companies, government health agencies, and others who can make change in the field.